Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyue Ding

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplantA Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Cancers|November 12, 2013
Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast CancerAshish B Rajput, Nianping Hu, Sonal Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Journal of Neuro-Oncology|January 19, 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19), Rebecca K S Wong, Nancy Paul, et al.
Journal of Neuro-Oncology|February 9, 2026
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Immunotherapy|November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trialsCourtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
American Journal of Human Genetics|June 25, 2011
Complement receptor 1 gene variants are associated with erythrocyte sedimentation rateIftikhar J Kullo, Keyue Ding, Khader Shameer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancerMing-Sound Tsao, Sarit Aviel-Ronen, Keyue Ding, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplantA Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Cancers|November 12, 2013
Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast CancerAshish B Rajput, Nianping Hu, Sonal Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Journal of Neuro-Oncology|January 19, 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19), Rebecca K S Wong, Nancy Paul, et al.
Journal of Neuro-Oncology|February 9, 2026
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Immunotherapy|November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trialsCourtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
American Journal of Human Genetics|June 25, 2011
Complement receptor 1 gene variants are associated with erythrocyte sedimentation rateIftikhar J Kullo, Keyue Ding, Khader Shameer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancerMing-Sound Tsao, Sarit Aviel-Ronen, Keyue Ding, et al.
Pageof 16